GeneriCo News Press Releases

GeneriCo, LLC Completes Transaction

ST. LOUIS, July 17, 2018 (GLOBE NEWSWIRE) — GeneriCo, LLC (GeneriCo), a specialty generic drug company, today announced that it completed a deal transaction with a leading US generic pharmaceutical company for the development and commercialization rights for three GeneriCo generic modified release product formulations.  Terms of the transaction were not disclosed. “We are pleased … Continued

GeneriCo News Press Releases

GeneriCo, LLC Prevails in Inter Partes Review of United States Patent 8,865,688

ST. LOUIS, May 19, 2017 (GLOBE NEWSWIRE) — GeneriCo, LLC (GeneriCo), a global specialty generic drug company, today announced that the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and Trademark Office ruled in favor of its petition for Inter Partes Review (“IPR”) of the Valeant Pharmaceuticals International, Inc. U.S. Patent 8,865,688 (the … Continued